Chirayu Amin (#2623)
- $ 2 B
- Pharmaceuticals
- India
- M
- 79 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Pharma tycoon Chirayu Amin's Alembic Pharmaceuticals is one of India's oldest pharma companies. Alembic was founded by Amin's grandfather in 1907 to make tincture and alcohol. Today, Alembic gets more than a third of its annual revenue from the domestic market selling generic drugs, including popular cough syrup Glycodin. While Amin is chairman and chief executive, his three sons work in different parts of the business.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Chirayu Amin’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Chirayu Amin’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.5B
(May 4, 2026)
© Iconic Billionaires